Search results
Jump to navigation
Jump to search
- {{r|Platelet}}618 bytes (73 words) - 13:59, 26 November 2010
- ...nal |author=Fritz E, Ludwig H, Scheithauer W, Sinzinger H |title=Shortened platelet half-life in multiple myeloma |journal=Blood |volume=68 |issue=2 |pages=514 ...s Disease. The chronic form in adults is usually caused by antibodies to [[Platelet glycoprotein GPIIb-IIIa complex]] or Ib-IX.<ref name="isbn0-7216-0187-1"/>4 KB (579 words) - 13:26, 23 November 2010
- {{r|Platelet}}335 bytes (40 words) - 07:01, 6 July 2024
- {{r|Platelet glycoprotein GPIIb-IIIa complex}}481 bytes (49 words) - 12:00, 22 September 2024
- .../> This leaves vasoconstriction, platelet aggregation, and thrombosis from platelet thromboxane A2 mediated by COX-1 intact.<ref name="pmid-16968830"/>2 KB (269 words) - 17:01, 3 August 2024
- {{r|Platelet}}619 bytes (80 words) - 21:25, 11 January 2010
- ...actor complex. The von Willebrand factor has receptors for [[collagen]], [[platelet]]s, and [[ristocetin]] activity as well as the immunologically distinct ant629 bytes (86 words) - 17:31, 10 July 2010
- {{r|Platelet}}631 bytes (71 words) - 07:01, 20 August 2024
- {{r|Platelet||**}}670 bytes (79 words) - 17:00, 19 July 2024
- {{r|Platelet}}438 bytes (54 words) - 12:00, 13 August 2024
- {{r|Platelet}}834 bytes (105 words) - 19:56, 11 January 2010
- {{r|Platelet}}562 bytes (73 words) - 17:00, 10 July 2024
- {{r|Platelet}}706 bytes (86 words) - 12:00, 23 August 2024
- ...'''cangrelor''' is an [[purinergic P2Y receptor antagonist]]s that is a [[platelet aggregation inhibitor]]. ...Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW et al.| title=Effect of platelet inhibition with cangrelor during PCI on ischemic events. | journal=N Engl J6 KB (873 words) - 12:25, 27 August 2013
- Nancy Sculerati has already built an extensive "Platelet" page that I didn't notice before building this "Platelets" page. There was665 bytes (106 words) - 14:29, 15 February 2007
- {{r|Platelet}}740 bytes (86 words) - 17:00, 3 August 2024
- {{r|Platelet transfusion}}816 bytes (122 words) - 01:41, 15 November 2010
- {{r|Platelet}}777 bytes (97 words) - 12:01, 31 July 2024
- ...antagonize or impair any mechanism leading to blood [[platelet activation|platelet aggregation]], whether during the phases of activation and shape change or Inhibitors of the [[platelet glycoprotein GPIIb-IIIa complex]] (GPIs) include the [[monoclonal antibody]4 KB (543 words) - 01:43, 8 May 2013
- {{r|Platelet}}776 bytes (95 words) - 17:00, 11 July 2024